Page 5 - CANNABIDIOL (CBD) Critical Review Report Geneva, 4-7 June 2018 World Health Organization
P. 5
Cannabidiol (CBD)
Acknowledgements
This report has been drafted under the responsibility of the WHO Secretariat, Department of
Essential Medicines and Health Products, Team of Innovation, Access and Use. The report is
an update and extension of the pre-review on cannabidiol, that was prepared by Prof Jason
th
White, Adelaide, Australia, for the 39 ECDD meeting in November 2017. The WHO
Secretariat would like to thank the following people for their contribution in producing this
review report: Dr Sharon Walsh and Dr Susanna Babalonis, Kentucky USA (update and
extension search, review and drafting), and J. Rehm et al, Toronto, Canada (analysis on
th
WHO questionnaire for the Review of Psychoactive Substances for the 40 ECDD:
evaluation of Cannabidiol, and report drafting).
4
